| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 942.50B | 757.64B | 734.72B | 654.74B | 645.05B |
| Gross Profit | 273.22B | 245.71B | 224.02B | 202.07B | 185.81B |
| EBITDA | 157.70B | 141.03B | 131.19B | 118.90B | 109.37B |
| Net Income | 82.88B | 74.83B | 68.16B | 64.52B | 55.31B |
Balance Sheet | |||||
| Total Assets | 2.81T | 2.69T | 2.25T | 2.11T | 2.04T |
| Cash, Cash Equivalents and Short-Term Investments | 169.83B | 140.32B | 102.96B | 61.38B | 102.91B |
| Total Debt | 1.60T | 1.55T | 1.19T | 1.12T | 991.74B |
| Total Liabilities | 2.01T | 1.94T | 1.56T | 1.45T | 1.42T |
| Stockholders Equity | 801.32B | 750.18B | 691.28B | 653.96B | 619.69B |
Cash Flow | |||||
| Free Cash Flow | 3.40B | -251.43B | 19.52B | -89.01B | 21.25B |
| Operating Cash Flow | 72.57B | -84.09B | 85.54B | -44.94B | 57.87B |
| Investing Cash Flow | -58.97B | -203.36B | -83.64B | -62.90B | -46.28B |
| Financing Cash Flow | 15.54B | 318.46B | 39.92B | 65.67B | -9.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥128.57B | 20.19 | 15.81% | 2.93% | 53.39% | 67.02% | |
73 Outperform | ¥4.42T | 16.16 | 9.64% | 0.97% | -1.33% | 25.13% | |
70 Outperform | ¥217.13B | 7.44 | 16.39% | 2.38% | 11.56% | 14.99% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | ¥1.37T | 19.14 | 13.29% | 3.25% | 24.50% | 11.52% | |
65 Neutral | ¥739.22B | 12.53 | 10.59% | 2.94% | 2.34% | -10.23% | |
56 Neutral | ¥914.31B | 10.45 | 7.40% | 3.68% | 24.40% | 11.46% |